Literature DB >> 25515155

The impact of LRP5 polymorphism (rs556442) on calcium homeostasis, bone mineral density, and body composition in Iranian children.

Elham Ashouri1, Elham Mahmoodi Meimandi2, Forough Saki1, Mohammad Hossein Dabbaghmanesh3, Gholamhossein Ranjbar Omrani1, Marzieh Bakhshayeshkaram4.   

Abstract

Failure to achieve optimal bone mass in childhood is the primary cause of decreased adult bone mineral density (BMD) and increased bone fragility in later life. Activating and inactivating LRP5 gene mutations has been associated with extreme bone-related phenotypes. Our aim was to investigate the role of LRP5 polymorphism on BMD, mineral biochemical parameters, and body composition in Iranian children. This cross-sectional study was performed on 9-18 years old children (125 boys, 137 girls). The serum level of calcium, phosphorous, alkaline phosphatase, and vitamin D parameters were checked. The body composition and BMD variables were measured by the Hologic system DXA. The rs566442 (V1119V) coding polymorphism in exon 15 of LRP5 was performed using PCR-RFLP method. Linear regression analysis, with adjustment for age, gender, body size parameters, and pubertal status was used to determine the association between LRP5 polymorphism (rs556442) and bone and body composition parameters. The allele frequency of the rs566442 gene was 35.5 % A and 63.9 % G. Our study revealed that LRP5 (rs556442) has not any significant influence on serum calcium, phosphorus, 25OHvitD, and serum alkaline phosphatase (P > 0.05). Total lean mass was greater in GG genotype (P = 0.028). Total body less head area (P = 0.044), spine BMD (P = 0.04), and total femoral BMC (P = 0.049) were lower in AG heterozygote genotype. This study show LRP5 polymorphism may associate with body composition and BMD in Iranian children. However, further investigations should be done to evaluate the role of other polymorphism.

Entities:  

Keywords:  Body composition; Bone mineral density; LRP5

Mesh:

Substances:

Year:  2014        PMID: 25515155     DOI: 10.1007/s00774-014-0624-4

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  33 in total

1.  Bone mineral acquisition in healthy Asian, Hispanic, black, and Caucasian youth: a longitudinal study.

Authors:  L K Bachrach; T Hastie; M C Wang; B Narasimhan; R Marcus
Journal:  J Clin Endocrinol Metab       Date:  1999-12       Impact factor: 5.958

2.  New approaches for interpreting projected bone densitometry data.

Authors:  D R Carter; M L Bouxsein; R Marcus
Journal:  J Bone Miner Res       Date:  1992-02       Impact factor: 6.741

3.  1,25-Dihydroxyvitamin D3 induces expression of the Wnt signaling co-regulator LRP5 via regulatory elements located significantly downstream of the gene's transcriptional start site.

Authors:  Jackie A Fretz; Lee A Zella; Sungtae Kim; Nirupama K Shevde; J Wesley Pike
Journal:  J Steroid Biochem Mol Biol       Date:  2007-01-16       Impact factor: 4.292

Review 4.  Wnt signaling in bone metabolism.

Authors:  Takuo Kubota; Toshimi Michigami; Keiichi Ozono
Journal:  J Bone Miner Metab       Date:  2009-03-31       Impact factor: 2.626

5.  Normative data and percentile curves of bone mineral density in healthy Iranian children aged 9-18 years.

Authors:  Marjan Jeddi; Mohammad Jafar Roosta; Mohammad Hossein Dabbaghmanesh; Gholamhossein Ranjbar Omrani; Sayed Mohammad Taghi Ayatollahi; Zahra Bagheri; Ali Reza Showraki; Marzieh Bakhshayeshkaram
Journal:  Arch Osteoporos       Date:  2013-01-08       Impact factor: 2.617

6.  Analysis of proximal femur DXA scans in growing children: comparisons of different protocols for cross-sectional 8-month and 7-year longitudinal data.

Authors:  H A McKay; M A Petit; D A Bailey; W M Wallace; R W Schutz; K M Khan
Journal:  J Bone Miner Res       Date:  2000-06       Impact factor: 6.741

7.  Six novel missense mutations in the LDL receptor-related protein 5 (LRP5) gene in different conditions with an increased bone density.

Authors:  Liesbeth Van Wesenbeeck; Erna Cleiren; Jeppe Gram; Rodney K Beals; Olivier Bénichou; Domenico Scopelliti; Lyndon Key; Tara Renton; Cindy Bartels; Yaoqin Gong; Matthew L Warman; Marie-Christine De Vernejoul; Jens Bollerslev; Wim Van Hul
Journal:  Am J Hum Genet       Date:  2003-02-10       Impact factor: 11.025

8.  Mutations in LRP5 cause primary osteoporosis without features of OI by reducing Wnt signaling activity.

Authors:  Johanna Korvala; Harald Jüppner; Outi Mäkitie; Etienne Sochett; Dirk Schnabel; Stefano Mora; Cynthia F Bartels; Matthew L Warman; Donald Deraska; William G Cole; Heini Hartikka; Leena Ala-Kokko; Minna Männikkö
Journal:  BMC Med Genet       Date:  2012-04-10       Impact factor: 2.103

9.  Lrp5 functions in bone to regulate bone mass.

Authors:  Yajun Cui; Paul J Niziolek; Bryan T MacDonald; Cassandra R Zylstra; Natalia Alenina; Daniel R Robinson; Zhendong Zhong; Susann Matthes; Christina M Jacobsen; Ronald A Conlon; Robert Brommage; Qingyun Liu; Faika Mseeh; David R Powell; Qi M Yang; Brian Zambrowicz; Han Gerrits; Jan A Gossen; Xi He; Michael Bader; Bart O Williams; Matthew L Warman; Alexander G Robling
Journal:  Nat Med       Date:  2011-05-22       Impact factor: 53.440

Review 10.  Where Wnts went: the exploding field of Lrp5 and Lrp6 signaling in bone.

Authors:  Bart O Williams; Karl L Insogna
Journal:  J Bone Miner Res       Date:  2009-02       Impact factor: 6.741

View more
  10 in total

1.  Effect of Cholecalciferol therapy on serum FGF23 in vitamin D deficient patients: a randomized clinical trial.

Authors:  T Kamelian; F Saki; M Jeddi; M H Dabbaghmanesh; G H R Omrani
Journal:  J Endocrinol Invest       Date:  2017-08-09       Impact factor: 4.256

2.  Association between serum uric acid and bone health in adolescents.

Authors:  F Karimi; M H Dabbaghmanesh; G R Omrani
Journal:  Osteoporos Int       Date:  2019-07-04       Impact factor: 4.507

3.  The rs3736228 polymorphism in the LRP5 gene is associated with calcaneal ultrasound parameter but not with body composition in a cohort of young Caucasian adults.

Authors:  María Correa-Rodríguez; Jacqueline Schmidt-RioValle; Blanca Rueda-Medina
Journal:  J Bone Miner Metab       Date:  2016-12-27       Impact factor: 2.626

4.  Protective effect of the olive hydroalcoholic extract on estrogen deficiency-induced bone loss in rats in comparison with estradiol.

Authors:  Farhad Koohpeyma; Mohammad Hossein Dabbaghmanesh; Mehrdokht Hajihoseini; Pedram Talezadeh; Nima Montazeri-Najafabady; Marzieh Bakhshayeshkaram
Journal:  Avicenna J Phytomed       Date:  2020 Nov-Dec

Review 5.  Lipoprotein receptor signalling in atherosclerosis.

Authors:  Chieko Mineo
Journal:  Cardiovasc Res       Date:  2020-06-01       Impact factor: 10.787

6.  Stereological investigation of the effect of Elaeagnus angustifolia fruit hydroalcoholic extract on osteoporosis in ovariectomized rats.

Authors:  Mohmmad Hossein Dabbaghmanesh; Ali Noorafshan; Pedram Talezadeh; Nader Tanideh; Farhad Koohpeyma; Aida Iraji; Marzieh Bakhshayeshkaram; Nima Montazeri-Najafabady
Journal:  Avicenna J Phytomed       Date:  2017 May-Jun

7.  LRP5 promotes cancer stem cell traits and chemoresistance in colorectal cancer.

Authors:  Xiaobo Nie; Huiyang Liu; Wenling Ye; Xiaoyun Wei; Lili Fan; Han Ma; Lanqing Li; Wanting Xue; Wenting Qi; Yan-Dong Wang; Wei-Dong Chen
Journal:  J Cell Mol Med       Date:  2022-01-07       Impact factor: 5.310

8.  Relative Importance of Lean and Fat Mass on Bone Mineral Density in Iranian Children and Adolescents.

Authors:  Marjan Jeddi; Mohammad Hossein Dabbaghmanesh; Gholamhossein Ranjbar Omrani; Sayed Mohammad Taghi Ayatollahi; Zahra Bagheri; Marzieh Bakhshayeshkaram
Journal:  Int J Endocrinol Metab       Date:  2015-07-01

9.  Investigating the Prevalence of Low Bone Mass in Children of Southern Iran and Its Associated Factors.

Authors:  Forough Saki; Gholamhossein Ranjbar Omrani; Marjan Jeddi; Marzie Bakhshaieshkaram; Mohammad Hossein Dabbaghmanesh
Journal:  Int J Endocrinol Metab       Date:  2017-07-26

10.  Association of Vitamin D Receptor BsmI Gene Polymorphism with BMD Z-Score in Iranian Children and Adolescents (9 - 18 Years Old).

Authors:  Nima Montazeri-Najafabady; Mohammad Hossein Dabbaghmanesh; Rajee Mohammadian Amiri; Mahdi Akbarzadeh
Journal:  Int J Endocrinol Metab       Date:  2019-04-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.